Shopping Cart
- Remove All
- Your shopping cart is currently empty
PF-06747711 is an effective and selective retinoic acid receptor-related orphan C2 inverse agonist (IC50: 4.1 nM). PF-06747711 also has anti-skin inflammatory activity.
Description | PF-06747711 is an effective and selective retinoic acid receptor-related orphan C2 inverse agonist (IC50: 4.1 nM). PF-06747711 also has anti-skin inflammatory activity. |
Targets&IC50 | RORC2:4.1 nM |
In vitro | PF-06747711 decreases IL-17 production by human Th17 cells (IC50: 9.5 nM) [1]. |
In vivo | In mice, PF-06747711 (10, 30, and 100 mg/kg, p.o., daily over 5 days) suppresses ear swelling in a dose-dependent manner[1]. |
Molecular Weight | 497.51 |
Formula | C26H26F3N5O2 |
Cas No. | 1892576-58-7 |
Relative Density. | 1.34 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 41.67 mg/mL (83.76 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.